(2) #2 Liposomal Curcumin Theres a lot of hype around curcumin these days, and for good reason
Choose 503A Compounding Pharmacy if: You need individualized prescriptions for specific patients The medication requires unique dosage forms or excipient modifications Youre operating in a setting where shorter BUDs are acceptable Choose 503B Compounding Pharmacy if: You need ready-to-use office stock for multiple patients Your facility requires standardized sterile preparations with longer BUDs You want additional safeguards from FDA cGMP compliance and inspections Quality, Safety, and Compliance Considerations 503A Pharmacies provide flexibility but rely heavily on USP compliance and state oversight
M., Kraft, P., Chasman, D., Willett, W
A spokesperson for Eli Lilly, which produces Zepbound and Mounjaro, told The Independent that Zepbound and Mounjaro autoinjectors and Zepbound vials are approved for single-use onlydose-splitting or microdosing is not contemplated by the FDA-label and may pose patient safety risks. Novo Nordisk, which produces Ozempic and Wegovy, told The Independent the company "[does] not condone the misuse of our products." The company noted it is concerned about non-FDA approved knock-off versions of semaglutide and sources spreading misinformation about GLP-1s to the public. The FDA warns that using unapproved versions of GLP-1 drugs can be risky for patients. This story was updated on September 4, 2025 to include responses from Eli Lilly and Novo Nordisk Join our commenting forum Join thought-provoking conversations, follow other Independent readers and see their replies Comments
